Who invested in Elixir Clinical Research?
Elixir Clinical Research's investors include Sinovation Ventures.
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$52Mraised across 1 round since 2022, from 1 source
Elixir Clinical Research's investors include Sinovation Ventures.
Elixir Clinical Research has raised $52M across 1 round since 2022.
Elixir Clinical Research's most recent round was a Series A of $52M in Apr 2022.
Its most recent round, $52M in Apr 2022, is also its largest on record.
Elixir Clinical Research's first round on record, in Apr 2022, was backed by Sinovation Ventures.
Elixir Clinical Research's latest named round is a Series A, in Apr 2022.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.